{"doi":"10.1146/annurev.immunol.21.120601.141007","title":"Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application","abstract":"<jats:p>▪ Abstract  Stem cell biology is scientifically, clinically, and politically a current topic. The hematopoietic stem cell, the common ancestor of all types of blood cells, is one of the best-characterized stem cells in the body and the only stem cell that is clinically applied in the treatment of diseases such as breast cancer, leukemias, and congenital immunodeficiencies. Multicolor cell sorting enables the purification not only of hematopoietic stem cells, but also of their downstream progenitors such as common lymphoid progenitors and common myeloid progenitors. Recent genetic approaches including gene chip technology have been used to elucidate the gene expression profile of hematopoietic stem cells and other progenitors. Although the mechanisms that control self-renewal and lineage commitment of hematopoietic stem cells are still ambiguous, recent rapid advances in understanding the biological nature of hematopoietic stem and progenitor cells have broadened the potential application of these cells in the treatment of diseases.</jats:p>","journal":"Annual Review of Immunology","year":2003,"id":35623,"datarank":16.18923295514863,"base_score":6.904750769961838,"endowment":6.904750769961838,"self_citation_contribution":1.035712615494276,"citation_network_contribution":15.153520339654355,"self_endowment_contribution":1.035712615494276,"citer_contribution":15.153520339654355,"corpus_percentile":null,"corpus_rank":null,"citation_count":996,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":8,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":182060,"name":"Amy J. Wagers","orcid":null,"position":1,"is_corresponding":false},{"id":182061,"name":"Markus G. Manz","orcid":null,"position":2,"is_corresponding":false},{"id":182062,"name":"Susan S. Prohaska","orcid":null,"position":3,"is_corresponding":false},{"id":182063,"name":"David C. Scherer","orcid":null,"position":4,"is_corresponding":false},{"id":182064,"name":"Georg F. Beilhack","orcid":null,"position":5,"is_corresponding":false},{"id":182065,"name":"Judith A. Shizuru","orcid":null,"position":6,"is_corresponding":false},{"id":29969,"name":"Irving L. Weissman","orcid":"0000-0002-9077-7467","position":7,"is_corresponding":false},{"id":182059,"name":"Motonari Kondo","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.904750769961838,"endowment":6.904750769961838,"datacite_reuse_total":8,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"12615892","pmcid":null,"openalex_id":"https://openalex.org/W2103054294","authors":[],"funders":[],"total_grants":0,"fwci":25.0719,"citation_percentile":0.99851723,"influential_citations":38,"citation_trend":[{"year":2012,"count":50},{"year":2013,"count":56},{"year":2014,"count":52},{"year":2015,"count":37},{"year":2016,"count":37},{"year":2017,"count":35},{"year":2018,"count":29},{"year":2019,"count":31},{"year":2020,"count":37},{"year":2021,"count":26},{"year":2022,"count":16},{"year":2023,"count":28},{"year":2024,"count":28},{"year":2025,"count":15},{"year":2026,"count":5}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://www.annualreviews.org/doi/pdf/10.1146/annurev.immunol.21.120601.141007","host_type":"publisher"},{"url":"https://doi.org/10.1146/annurev.immunol.21.120601.141007","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/12615892","host_type":"repository"}],"fields_of_study":["Hematopoietic Stem Cell Transplantation","Mesenchymal stem cell research","Virus-based gene therapy research","Biology","Medicine","Animals","Apoptosis","Autoimmune Diseases","Cell Differentiation","Cell Division","Cell Movement","Cell Separation","Diabetes Mellitus, Type 1","Female","Gene Expression Profiling","Hematopoiesis","Hematopoietic Stem Cells","Humans","Mice","Neoplasms"],"mesh_terms":["Animals","Autoimmune Diseases","Cell Differentiation","Cell Division","Cell Movement","Cell Separation","Diabetes Mellitus, Type 1","Female","Hematopoiesis","Hematopoietic Stem Cells","Humans","Neoplasms","Apoptosis","Hematopoietic Stem Cell Transplantation","Gene Expression Profiling","Mice"],"keywords":["Stem cell","Biology","Progenitor cell","Haematopoiesis","Cancer stem cell","Hematopoietic stem cell","Myeloid","Immunology","Adult stem cell","Endothelial stem cell","Cell biology","Stem cell theory of aging","Cancer research","Stem cell factor","Cellular differentiation","Genetics","Gene"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.20761546.v1","title":"Additional file 1 of Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20761546","title":"Additional file 1 of Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26637015.v1","title":"Additional file 1 of Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26637015","title":"Additional file 1 of Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26637018.v1","title":"Additional file 2 of Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26637018","title":"Additional file 2 of Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26637021.v1","title":"Additional file 3 of Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26637021","title":"Additional file 3 of Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-10T05:54:43.412914Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}